Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anticoagulation in Intracerebral Hemorrhage (ICH) Survivors for Stroke Prevention and Recovery

NCT03907046 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT03907046
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03907046 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anticoagulation in Intracerebral Hemorrhage (ICH) Survivors for Stroke Prevention and Recovery
Lead sponsor
Yale University
Phase
Phase 3
Overall status
Recruiting
Start date
January 28, 2020
Completion date
April 30, 2027
Enrollment
700 (estimated)
Sites
187

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, intracerebral hemorrhage